investingreview.org logo
Avoid Fraud, Get The Facts, And Find The Best
Nothings Found.

Assessing Searle & Co.'s Q3 2022 vs. Q4 2022 Fund Holdings: An In-Depth Analysis

Ava Hoppe | 2 May, 2023

Investors and traders are always keen on analyzing the portfolios of well-known investment firms and hedge funds. One such organization is Searle & Co., which is renowned for their diverse and robust holdings. In this article, we’ll delve into the fund's latest 13F filings and analyze the changes in their holdings from Q3 2022 to Q4 2022.

JPMorgan Chase & Co. (JPM) remained the top stock in Searle & Co.'s portfolio, with 261,117 shares in both Q3 2022 and Q4 2022. The value of the holding, however, increased by 28.3%, from $27,287,000 to $35,015,000.

Apple Inc. (AAPL) was the second-largest holding in both quarters, with an increase in shares from 119,629 to 125,229. However, the value of the holding decreased from $16,533,000 in Q3 2022 to $16,271,000 in Q4 2022, a decrease of 1.6%.

Microsoft Corporation (MSFT) ranked third in Searle & Co.'s portfolio, with an increase in shares from 37,087 to 38,387. The value of the holding also increased from $8,638,000 to $9,205,000, an increase of 6.6%.

ExxonMobil Corporation (XOM) ranked fourth in the portfolio, with a decrease in shares from 80,497 to 75,265. However, the value of the holding increased from $7,028,000 to $8,301,000, a strong increase of 18.1%.

Johnson & Johnson (JNJ) maintained its position as the fifth-largest holding, with 40,825 shares in both Q3 2022 and Q4 2022. The value of the holding increased from $6,669,000 to $7,211,000, an increase of 8.1%.

AbbVie Inc. (ABBV) ranked sixth in the portfolio, with a decrease in shares from 44,775 to 44,447. However, the value of the holding increased from $6,009,000 to $7,183,000, a strong increase of 19.5%.

Bristol-Myers Squibb Co. (BMY) ranked seventh in Searle & Co.'s portfolio, with 93,256 shares in both quarters. The value of the holding increased slightly from $6,630,000 to $6,709,000, a marginal increase of 1.2%.

Bank of America Corp. (BAC) ranked eighth in the portfolio, with 201,060 shares in both Q3 2022 and Q4 2022. The value of the holding increased from $6,072,000 to $6,659,000, an increase of 9.7%.

McDonald's Corporation (MCD) ranked ninth in Searle & Co.'s portfolio, with an increase in shares from 20,182 to 20,664. The value of the holding increased from $4,657,000 to $5,445,000, an increase of 16.9%.

Nucor Corporation (NUE) ranked tenth in the portfolio, with 40,783 shares in both quarters. However, the value of the holding increased significantly from $4,363,000 to $5,375,000, a strong increase of 23.2%.

Caterpillar Inc. (CAT) ranked eleventh in the portfolio, with 21,064 shares in both quarters. The value of the holding increased significantly from $3,456,000 to $5,046,000, a strong increase of 46%.

The remaining positions in Searle & Co.'s top holdings underwent some notable changes. Rockwell Automation Inc. (ROK) rose by 19.7%, while Honeywell Int'l Inc. (HON) increased by 37.9%, reflecting the market's general preference for industrial stocks. Horizon Therapeutics Pub L (HZNP) rose by an outstanding 83.9%, whereas Palo Alto Networks Inc. (PANW) fell 15.4%.

In summary, there were a few significant changes in Searle & Co.'s portfolio from Q3 2022 to Q4 2022. The value of the portfolio increased by 19.1%, from $210,699,000 to $250,843,000, with twenty-one stocks experiencing a change in the number of shares held. JPM, AAPL, and MSFT still remained the top three holdings, whereas CAT, HON, and HZNP showed strong growth in their value. This analysis provides investors with valuable insights into how the top holdings of Searle & Co. experienced changes between these two quarters.

Many people have been burned by frauds and Ponzi schemes. So we created this website to help you, the potential investor, get the facts, find the best, and avoid fraud and Ponzi schemes.

All information provided on this website is provided without warranty and for informational purposes only.
InvestingReview.org does not provide investment advice. InvestingReview.org is not an investment adviser and is not endorsed by or affiliated with any U.S. or non-U.S. regulatory agency.


Recently Searched Firms

Please note: Search data is accumulated by 3rd party and refreshed once per day.

Copyright © 2023 by InvestingReview.org / All Rights Reserved.